Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Inspire Medical Systems (INSP) Change in Cash (2017 - 2025)

Inspire Medical Systems' Change in Cash history spans 9 years, with the latest figure at -$8.0 million for Q4 2025.

  • For Q4 2025, Change in Cash fell 404.47% year-over-year to -$8.0 million; the TTM value through Dec 2025 reached -$45.3 million, down 28.12%, while the annual FY2025 figure was -$45.3 million, 28.12% down from the prior year.
  • Change in Cash for Q4 2025 was -$8.0 million at Inspire Medical Systems, down from $5.9 million in the prior quarter.
  • Across five years, Change in Cash topped out at $231.2 million in Q3 2022 and bottomed at -$144.4 million in Q4 2023.
  • The 5-year median for Change in Cash is -$2.6 million (2021), against an average of -$4.3 million.
  • The largest annual shift saw Change in Cash skyrocketed 587.0% in 2022 before it tumbled 1974.26% in 2024.
  • A 5-year view of Change in Cash shows it stood at $4.3 million in 2021, then soared by 457.39% to $23.8 million in 2022, then tumbled by 706.96% to -$144.4 million in 2023, then surged by 101.83% to $2.6 million in 2024, then crashed by 404.47% to -$8.0 million in 2025.
  • Per Business Quant, the three most recent readings for INSP's Change in Cash are -$8.0 million (Q4 2025), $5.9 million (Q3 2025), and $53.0 million (Q2 2025).